瓣膜性心脏病经导管介入治疗并发机械性溶血:JACC前沿综述
该综述聚焦瓣膜病矫正前后发生的机械性血管内溶血,阐述其病理生理、诊断方法及其他血液学状况对贫血的影响,强调多学科管理的重要性,并提供人工瓣膜植入后亚临床溶血的实验室数据及治疗选择。
要点
- 瓣膜介入术后机械性溶血常见但多轻微,少数可致严重贫血需输血或肾脏替代治疗。
- 诊断需结合实验室溶血指标,并注意其他血液学疾病对贫血的叠加影响。
- 管理强调多学科协作,治疗包括药物和手术,无法手术者有多种替代选择。
核心结论
- 机械性血管内溶血在瓣膜介入术后常见,多数轻微,但可临床显著甚至危及生命。
研究设计与样本
- JACC前沿综述,总结瓣膜病矫正前后机械性溶血的现有知识。
主要发现
- 瓣膜术后机械性溶血常见,而原生瓣膜病中不常见。
- 多数溶血严重程度轻微,但可需多次输血和肾脏替代治疗。
- 综述提供了手术和经导管瓣膜假体及装置植入后亚临床溶血的实验室数据。
临床怎么用
- 临床应关注瓣膜介入术后溶血,结合实验室指标识别亚临床溶血。
- 严重溶血需多学科管理,包括输血、肾脏替代及药物或手术治疗。
- 无法手术的患者可考虑替代治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mechanical intravascular hemolysis is frequently observed following procedures on heart valves and uncommonly observed in native valvular disease. In most cases, its severity is mild. Nevertheless, it can be clinically significant and even life threatening, requiring multiple blood transfusions and renal replacement therapy. This paper reviews the current knowledge on mechanical intravascular hemolysis in valvular disease, before and after correction, focusing on pathophysiology, approach to diagnosis, and impact of other hematological conditions on the resultant anemia. The importance of a multidisciplinary management is underscored. Laboratory data are provided about subclinical hemolysis that is commonly observed following the implantation of surgical and transcatheter valve prostheses and devices. Finally, clinical scenarios are reviewed and current medical and surgical treatments are discussed, including alternative options for inoperable patients.
引用
- Cannata A, Cantoni S, Sciortino A, et al. Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 33958130. doi:10.1016/j.jacc.2021.03.295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。